Nasr A, Copeland N, Munir M
Genes (Basel). 2024; 15(11).
PMID: 39596561
PMC: 11594476.
DOI: 10.3390/genes15111361.
Li K, Xie X, Gao R, Chen Z, Yang M, Wen Z
Nat Chem. 2024; 17(1):111-123.
PMID: 39501047
DOI: 10.1038/s41557-024-01663-1.
Orji O, Stones J, Rajani S, Markus R, Demirbugen Oz M, Knight H
Mol Neurobiol. 2024; 62(4):5006-5021.
PMID: 39499421
PMC: 11880056.
DOI: 10.1007/s12035-024-04555-0.
Wang C, Zhou H
RSC Chem Biol. 2024; 5(9):914-923.
PMID: 39211476
PMC: 11353026.
DOI: 10.1039/d4cb00105b.
Yang Y, Lu Y, Wang Y, Wen X, Qi C, Piao W
Front Cell Dev Biol. 2024; 12:1392159.
PMID: 39055651
PMC: 11269109.
DOI: 10.3389/fcell.2024.1392159.
Loss of Epitranscriptomic Modification N-Methyladenosine (mA) Reader YTHDF1 Exacerbates Ischemic Brain Injury in a Sexually Dimorphic Manner.
Chokkalla A, Arruri V, Mehta S, Vemuganti R
Transl Stroke Res. 2024; .
PMID: 38869772
DOI: 10.1007/s12975-024-01267-4.
ZDHHC20-mediated S-palmitoylation of YTHDF3 stabilizes MYC mRNA to promote pancreatic cancer progression.
Zhang H, Sun Y, Wang Z, Huang X, Tang L, Jiang K
Nat Commun. 2024; 15(1):4642.
PMID: 38821916
PMC: 11143236.
DOI: 10.1038/s41467-024-49105-3.
Understanding the redundant functions of the mA-binding YTHDF proteins.
Zaccara S, Jaffrey S
RNA. 2024; 30(5):468-481.
PMID: 38531646
PMC: 11019742.
DOI: 10.1261/rna.079988.124.
YTHDF2 governs muscle size through a targeted modulation of proteostasis.
Gilbert C, Rabolli C, Golubeva V, Sattler K, Wang M, Ketabforoush A
Nat Commun. 2024; 15(1):2176.
PMID: 38467649
PMC: 10928198.
DOI: 10.1038/s41467-024-46546-8.
Advances in DNA, histone, and RNA methylation mechanisms in the pathophysiology of alcohol use disorder.
Cruise T, Kotlo K, Malovic E, Pandey S
Adv Drug Alcohol Res. 2024; 3:10871.
PMID: 38389820
PMC: 10880780.
DOI: 10.3389/adar.2023.10871.
O-GlcNAcylation determines the translational regulation and phase separation of YTHDF proteins.
Chen Y, Wan R, Zou Z, Lao L, Shao G, Zheng Y
Nat Cell Biol. 2023; 25(11):1676-1690.
PMID: 37945829
DOI: 10.1038/s41556-023-01258-x.
Dysregulation of RNA modification systems in clinical populations with neurocognitive disorders.
Knight H, Demirbugen Oz M, PerezGrovas-Saltijeral A
Neural Regen Res. 2023; 19(6):1256-1261.
PMID: 37905873
PMC: 11467953.
DOI: 10.4103/1673-5374.385858.
Insights into the conservation and diversification of the molecular functions of YTHDF proteins.
Flores-Tellez D, Tankmar M, von Bulow S, Chen J, Lindorff-Larsen K, Brodersen P
PLoS Genet. 2023; 19(10):e1010980.
PMID: 37816028
PMC: 10617740.
DOI: 10.1371/journal.pgen.1010980.
Loss of YTHDF2 Alters the Expression of mA-Modified Myzap and Causes Adverse Cardiac Remodeling.
Golubeva V, Dorn L, Gilbert C, Rabolli C, Das A, Wanasinghe V
JACC Basic Transl Sci. 2023; 8(9):1180-1194.
PMID: 37791304
PMC: 10543918.
DOI: 10.1016/j.jacbts.2023.03.012.
Ghost authors revealed: The structure and function of human N -methyladenosine RNA methyltransferases.
Breger K, Kunkler C, OLeary N, Hulewicz J, Brown J
Wiley Interdiscip Rev RNA. 2023; :e1810.
PMID: 37674370
PMC: 10915109.
DOI: 10.1002/wrna.1810.
Characterization of epitranscriptome reader proteins experimentally and : Current knowledge and future perspectives beyond the YTH domain.
Miller L, Demny M, Tamamis P, Contreras L
Comput Struct Biotechnol J. 2023; 21:3541-3556.
PMID: 37501707
PMC: 10371769.
DOI: 10.1016/j.csbj.2023.06.018.
Roles and implications of mRNA N -methyladenosine in cancer.
Zeng L, Huang X, Zhang J, Lin D, Zheng J
Cancer Commun (Lond). 2023; 43(7):729-748.
PMID: 37350762
PMC: 10354418.
DOI: 10.1002/cac2.12458.
Comprehensive Analysis of Genes, Encoding mA Reader and Their Response to Temperature Stresses and Infection in Rainbow Trout ().
Yu H, Gao Q, Wang W, Liu D, He J, Tian Y
Int J Mol Sci. 2023; 24(11).
PMID: 37298300
PMC: 10253868.
DOI: 10.3390/ijms24119348.
N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms.
Chen L, Gao Y, Xu S, Yuan J, Wang M, Li T
Front Immunol. 2023; 14:1162607.
PMID: 36999016
PMC: 10043241.
DOI: 10.3389/fimmu.2023.1162607.
The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications.
Liu Z, Gao L, Cheng L, Lv G, Sun B, Wang G
Exp Mol Med. 2023; 55(3):487-501.
PMID: 36854773
PMC: 10073155.
DOI: 10.1038/s12276-023-00944-y.